Patrick Vilela

Patrick Vilela

Auto-generated profile, based on publicly available information

Patrick Vilela

Department of Chemical and Structural Biology Weizmann Institute of Science Rehovot Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in The EMBO Journal
Verified
Journal Article
Open access
TITal Ilani
Tal Ilani
NRNava Reznik
Nava Reznik
NYNoa Yeshaya
Noa Yeshaya
TFTal Feldman
Tal Feldman
PVPatrick Vilela
Patrick Vilela
DFDeborah Fass
Deborah Fass
Mucus is made of enormous mucin glycoproteins that polymerize by disulfide crosslinking in the Golgi apparatus. QSOX1 is a catalyst of disulfide bond formation localized to the Golgi. Both QSOX1 and mucins are highly expressed in goblet cells of mucosal tissues, leading to the hypothesis that QSOX1 catalyzes disulfide‐mediated mucin polymerization. We found that knockout mice lacking QSOX1 had impaired mucus barrier function due to production of defective mucus. However, an investigation on the molecular level revealed normal disulfide‐mediated polymerization of mucins and related glycoproteins. Instead, we detected a drastic decrease in sialic acid in the gut mucus glycome of the QSOX1 knockout mice, leading to the discovery that QSOX1 forms regulatory disulfides in Golgi glycosyltransferases. Sialylation defects in the colon are known to cause colitis in humans. Here we show that QSOX1 redox control of sialylation is essential for maintaining mucosal function.